Stock REMI REMEDENT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Remedent, Inc.

Equities

REMI

US75954T1043

Market Closed - OTC Markets
Other stock markets
 09:40:02 2024-06-17 EDT 		5-day change 1st Jan Change
0.06 USD +9.09% Intraday chart for Remedent, Inc. -.--% -38.14%
2023 Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
2022 Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022
CI
Remedent : Attorney Letter - Lockett + Horwitz - Remedent, Inc. 2022-06-30 - re Annual Report
PU
Remedent : Annual Report for Year Ended March 31, 2022
PU
REMEDENT, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Remedent, Inc. Files Form 15 to Suspend SEC Exchange Act Registration and Applies to Qualify for OTC Markets Alternative Reporting Standard for Pink Sheet Companies
GL
Remedent announces its agreement with Aurum Ceramic Dental Laboratories Co., concerning an Exclusive Master License Agreement in reference to its GlamSmile Veneers and Technology
GL
Remedent Announces Agreement with Aurum Ceramic Dental Laboratories Co., Concerning an Exclusive Master License Agreement in Reference to Its Glamsmile Veneers and Technology
CI
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2020
CI
Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2020
CI
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Remedent, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2020
CI
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
REMEDENT : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2020
CI
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2019
CI
Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2019
CI
Remedent, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2019
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. REMI Stock
  4. News Remedent, Inc.